A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
34.81 +0.13 (0.37%) CRL

Click Here to Receive Instant E-mail and RSS Alerts


Trade CRL now with

Stock Details

Last Trade:34.81 Change:+0.13 (0.37%) Prev Close:34.68 Open: 34.71 Days Range:34.50 – 35.24 52 Week Range: 25.52 - 42.68 Volume:378535 P/E: N/A
EPS:-3.68





Recent Blog Posts

Blog Posts on 01/29/12 at 4:34am
Arena Pharmaceuticals Has Over A 300% Upside Potential In 2012
Blog Posts on 01/18/12 at 9:08am
10 Biotech Stocks With Strong Corporate Governance
Blog Posts on 01/17/12 at 4:23am
Arena Pharmaceuticals Faces FDA Decision For Second Time
Blog Posts on 01/12/12 at 8:23pm
Contract Research Organizations Still On Sale As Industry Rebounds
Blog Posts on 01/11/12 at 1:19am
Hedge Funds Are Selling These 6 Biotech Stocks
Blog Posts on 12/29/11 at 3:24pm
Top 10 Biotech Stocks Loved By Hedge Funds
Blog Posts on 12/20/11 at 4:02pm
AP Pharma's APF530 Poised To Return To FDA Review
Blog Posts on 12/14/11 at 1:56pm
Charles River Laboratories' CEO Issues 2012 Guidance - Guidance Call Transcript
Blog Posts on 12/11/11 at 2:13am
20 Biotech Stocks That Hedge Funds Are Selling
Blog Posts on 12/08/11 at 1:49pm
8 Big Sells By Hedge Funder Barry Rosenstein
Blog Posts on 12/01/11 at 8:44am
Top Stock Picks From John Rogers
Blog Posts on 11/23/11 at 5:12pm
Transcept Wins FDA OK For Insomnia Drug, What's Next?
Blog Posts on 11/03/11 at 10:02am
5 Stocks To Buy Now For Big Profits In 2012
Blog Posts on 11/02/11 at 2:43pm
Charles River Laboratories' CEO Discusses Q3 2011 Results - Earnings Call Transcript
Blog Posts on 10/13/11 at 1:25pm
Contrarian David Dreman's Long-Term Stock Picks
Blog Posts on 10/06/11 at 10:09am
David Dreman's 15 Favorite Stock Picks
Blog Posts on 10/05/11 at 3:37am
20 Biotech Stocks With Strong Corporate Governance
Blog Posts on 10/03/11 at 7:10pm
Leading CROs Will Gain From Drug Research Rebound
Blog Posts on 09/14/11 at 1:39pm
6 Potential Activist Targets For Jana Partners
Blog Posts on 09/12/11 at 4:59am
Is Arena's Lorcaserin On Track For Approval In 2012?
Blog Posts on 09/02/11 at 8:55am
Top 10 Biotech Stocks Loved By Hedge Funds
Blog Posts on 08/30/11 at 12:42am
10 Biotech Stocks Being Dumped By Big Money Managers
Blog Posts on 08/28/11 at 10:49am
David Dreman's Favorite Stock Picks
Blog Posts on 08/23/11 at 6:46pm
5 More Stocks To Buy Now For Payoff In 2012
Blog Posts on 08/18/11 at 12:19pm
Jana Partners' Picks: El Paso, McGraw-Hill
Blog Posts on 08/16/11 at 12:19pm
Jana Partners' Top Stock Picks
Blog Posts on 08/15/11 at 3:24pm
A Look at 2 Undervalued Biotech Stocks
Blog Posts on 08/15/11 at 7:23am
5 Unique Stocks to Buy Now for Big Profits in 2012
Blog Posts on 08/10/11 at 4:11pm
Arena Updates Investors on Its Handling of Carcinogenicty Issues Related to Lorcaserin
Blog Posts on 08/09/11 at 2:11pm
Alexza's Agitation Drug Back Under Review - Trade the Upcoming Catalysts